SUAKOKO · BONG COUNTY · LIBERIAFaculty room
PHEBENURSE ANESTHESIA

Education with purpose.
Care for Liberia.

How to apply

NANE 103 · WEEK 12 · CLASS 17

Opiate Agonists Antagonists and Antiemetics

Guided study notes · January 18–24, 2027

Back to Week 12

Nausea and vomiting pathways, receptor targets and antiemetic classes, fentanyl-family potency and dosing, naloxone reversal, and recurrence of respiratory depression.

Watch this lecture on YouTube

Learning objectives

  • Map major inputs to the vomiting center and chemoreceptor trigger zone.
  • Match antiemetic drug classes to receptor targets.
  • Compare fentanyl-family potency and unit conventions.
  • Use naloxone titration and monitoring principles to reverse respiratory depression safely.

Complete the blanks as you watch. Use the time ranges to pause, review and discuss the key ideas with your faculty.

00:00 to 25:00

Vomiting Pathways

  1. The vomiting center integrates input from the gastrointestinal tract, vestibular system, cortex, and chemo________________ trigger zone.
  2. The chemoreceptor trigger zone is located in the ________________.
  3. Because the ________________ barrier is limited there, the trigger zone can detect circulating emetogenic substances.
  4. ________________s can stimulate the trigger zone and slow gastric emptying, both contributing to nausea.

20:00 to 45:00

Antiemetic Receptors and Classes

  1. Common antiemetic targets include serotonin 5-HT3, dopamine D2, histamine H1, muscarinic M1, and neurokinin ________________.
  2. Ondansetron and related drugs block 5-HT3 ________________s.
  3. Droperidol and metoclopramide have dopamine-ant________________ activity with different additional effects.
  4. Multimodal ________________ combines agents from different classes according to patient risk.

45:00 to 60:00

Fentanyl Family and Potency

  1. Fentanyl is substantially more potent than morphine and is commonly dosed in ________________.
  2. Sufentanil and remifentanil are even more potent, so unit and ________________ checks are critical.
  3. ________________ is rapidly metabolized by nonspecific esterases.
  4. Potency does not remove opioid class effects such as ________________ and rigidity.

60:00 to 75:00

Naloxone Titration

  1. Naloxone is a competitive opioid receptor ________________.
  2. Small titrated doses can restore ________________ while limiting abrupt loss of analgesia.
  3. Large abrupt doses may cause pain, ________________ activation, withdrawal, or pulmonary complications.
  4. The goal is adequate ________________ and airway protection rather than necessarily complete arousal.

75:00 to 84:12

Monitoring After Reversal

  1. ________________ may have a shorter duration than the opioid being reversed.
  2. Recurrent respiratory depression is called ________________.
  3. Continued monitoring must account for ________________ dose, formulation, route, organ function, and co-sedatives.
  4. Repeated ________________ doses or an infusion may be required when a long-acting opioid remains active.

Notes & questions for class

Lecture recorded in 2017. Use current local protocols and faculty guidance for clinical decisions.